InVivo Therapeutics Holdings Corp. (NVIV)
InVivo Therapeutics Holdings Corp. (NVIV)
$0.68 USD
0.00 (0.00%)
Updated Jul 17 10:39am
Add NVIV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
NVIV Daily Price Range
NVIV 52-Week Price Range
NVIV News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
The Expansion Continues for Aurora Cannabis (ACB)
Hexo Corp. (HEXO) began trading on the NYSE today, here’s what it means for the stock
Best & Worst Performing Stock Industries for July 16, 2019
Best & Worst Performing Small Cap Stocks for July 16, 2019
Best & Worst Performing Large Cap Stocks for July 16, 2019
View All Top StoriesInVivo Therapeutics Holdings Corp. (NVIV) Company Bio
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 and is based in Cambridge, Massachusetts.
NVIV Stock Chart More Charts
NVIV Price/Volume Stats
| Current price | $0.68 |
| Prev. close | $0.68 |
| Day low | $0.65 |
| Day high | $0.68 |
| 50-day MA | $0.91 |
| 200-day MA | $1.50 |
| 52-week high | $2.75 |
| 52-week low | $0.61 |
| Volume | 8,372 |
| Avg. volume | 66,789 |
| Dividend yield | N/A |
| Market Cap | 6.33M |
NVIV Returns
| 1-mo | -5.56% |
| 3-mo | -55.56% |
| 6-mo | -56.96% |
| 1-year | -66.83% |
| 3-year | -99.56% |
| 5-year | -99.33% |
| YTD | -54.97% |
| 2018 | -92.16% |
| 2017 | -81.67% |
| 2016 | -41.67% |
| 2015 | 36.36% |
| 2014 | -42.51% |
Loading social stream, please wait...